Modern nuclear cardiac imaging in diagnosis and clinical management of patients with left ventricular dysfunction

Minerva Cardioangiologica

Volumn 52, Issue 6, 2004, Pages 505-519

  Abidov, A ^a   Hachamovitch, R ^b   Berman, D S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Coronary disease; Ischemic cardiomyopathy; Myocardial perfusion; Myocardial revascularization; Nuclear cardiology; Prognosis; Tomography, emission computed; Tomography, emission computed single photon; Ventricular dysfunction, left, diagnosis

Indexed keywords

CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE VOLUME; HUMAN; ISCHEMIA; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVASCULARIZATION; REVIEW; RISK BENEFIT ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FORECASTING; HUMANS; MYOCARDIAL REVASCULARIZATION; RADIONUCLIDE VENTRICULOGRAPHY; RISK ASSESSMENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 12144279181     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Heart Disease and Stroke Statistics - 2004 Update. Dallas, TX: American Heart Association; 2003.
2. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 1986;8:1467-70.
3. Braunwald E. The stunned myocardium: newer insights into mechanisms and clinical implications. J Thorac Cardiovasc Surg 1990;100:310-1.
4. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
5. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
6. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
7. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
8. th edition. New York: McGraw-Hill Companies; 2004.
9. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
10. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.
11. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.
12. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004;11:414-23.
13. Erel J, Kiat H, Friedman JD, Germano G, Berman DS. The added diagnostic value of gating to exercise Tc-99m sestamibi SPECT for detection of coronary artery disease. J Nucl Med 1996;37:149P.
14. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70.
15. Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990;66:1163-70.
16. Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612-20.
17. Takeishi Y, Chiba J, Abe S, Komatani A, Takahashi K, Tomoike H. Noninvasive identification of left main and three-vessel coronary artery disease by thallium-201 single photon emission computed tomography during adenosine infusion. Ann Nucl Med 1994;8:1-7.
18. Hansen CL, Sangrigoli R, Nkadi E, Kramer M. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging. J Am Coll Cardiol 1999;33:1323-7.
19. Romanens M, Gradel C, Saner H, Pfisterer M. Comparison of 99mTc-sestamibi lung/heart ratio, transient ischaemic dilation and perfusion defect size for the identification of severe and extensive coronary artery disease. Eur J Nucl Med 2001;28:907-10.
20. Abidov A, Hayes SW, Friedman JD et al. Ischemic stunning and transient ischemic dilation are important diagnostic markers of significant CAD in patients with normal myocardial perfusion SPECT. J Nucl Med 2003;Suppl:3P.
21. Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.
22. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
23. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999;281:524-9.
24. Azarbal B, Hayes SW, Lewin HC, Hachamovitch R, Cohen I, Berman DS. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion SPECT in the prediction of cardiac death and all-cause mortality: superiorityt over 85% of age-predicted maximal heart rate. J Am Coll Cardiol 2004;44:423-30.
25. Abidov A, Hachamovitch R, Hayes SW, Ng CK, Cohen I, Friedman JD et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation 2003;107:2894-9.
26. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831-7.
27. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC et al. Incremental prognostic value of poststress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
28. Hachamovitch R, Hayes SW, Cohen I, Germano G, Berman DS. Inducible ischemia is superior to EF for identification of short-term survival benefit with revascularization vs medical therapy. Circulation 2002;106 Suppl:II-523.
29. Rahimtoola SH. Coronary bypass surgery for chronic angina-1981. A perspective. Circulation 1982;65:225-41.
30. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
31. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Rokhsar S, Maddahi J. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction. J Nucl Cardiol 1998;5:558-66.
32. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
33. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 1995;75:17A-25A.
34. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R, Knuuti J et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
35. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng W et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997;95:1961-71.
36. Bax JJ, Maddahi J, Poldermans D, Elhendy A, Cornel JH, Boersma E et al. Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med 2002;43:795-802.
37. Bax JJ, Van Der Wall EE, Schalij MJ. Prognostic value of left ventricular dyssynchrony in patients with heart failure. J Am Coll Cardiol 2004;44:937, author reply 937-8.
38. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med 2004;45 Suppl 1:36S-45S.